These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2263809)

  • 1. Recent advances in endometrial cancer.
    Creasman WT; Eddy GL
    Semin Surg Oncol; 1990; 6(6):339-42. PubMed ID: 2263809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised FIGO staging system for endometrial cancer.
    Lewin SN
    Clin Obstet Gynecol; 2011 Jun; 54(2):215-8. PubMed ID: 21508690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and recurrent patterns in Stage I endometrial cancer.
    DiSaia PJ; Creasman WT; Boronow RC; Blessing JA
    Am J Obstet Gynecol; 1985 Apr; 151(8):1009-15. PubMed ID: 3985062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis and treatment of endometrial cancer.
    Berman ML; Ballon SC; Lagasse LD; Watring WG
    Am J Obstet Gynecol; 1980 Mar; 136(5):679-88. PubMed ID: 7355948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy.
    DiSaia PJ; Creasman WT
    Clin Obstet Gynaecol; 1986 Dec; 13(4):751-65. PubMed ID: 3791829
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of the extent of cervical involvement by endometrial cancer.
    Fanning J; Alvarez PM; Tsukada Y; Piver MS
    Gynecol Oncol; 1991 Jan; 40(1):46-7. PubMed ID: 1989914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
    Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
    J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial carcinoma: current concepts and future perspectives.
    Lindahl B
    Crit Rev Oncol Hematol; 1990; 10(4):315-26. PubMed ID: 2278640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphvascular space involvement--a prognostic indicator in endometrial adenocarcinoma.
    Gal D; Recio FO; Zamurovic D; Tancer ML
    Gynecol Oncol; 1991 Aug; 42(2):142-5. PubMed ID: 1894173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus.
    Yamada SD; Burger RA; Brewster WR; Anton D; Kohler MF; Monk BJ
    Cancer; 2000 Jun; 88(12):2782-6. PubMed ID: 10870061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and prognosis in stage II endometrial cancer.
    Berman ML; Afridi MA; Kanbour AI; Ball HG
    Gynecol Oncol; 1982 Aug; 14(1):49-61. PubMed ID: 7095588
    [No Abstract]   [Full Text] [Related]  

  • 12. Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups.
    Mittal KR; Schwartz PE; Barwick KW
    Cancer; 1988 Feb; 61(3):538-45. PubMed ID: 3338021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histomorphologic prognostic factors in stage I endometrial cancers].
    Köhler U; Bilek K; Rosenkranz M
    Zentralbl Gynakol; 1987; 109(20):1245-54. PubMed ID: 3425025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
    Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
    Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
    Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
    J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial cancer: therapeutic decision and the staging process in "early" disease.
    Lewis GC; Mortel R; Slack NH
    Cancer; 1977 Feb; 39(2 Suppl):959-66. PubMed ID: 319900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
    Jalloul RJ; Elshaikh MA; Ali-Fehmi R; Haley MM; Yoon J; Mahan M; Munkarah AR
    Int J Gynecol Cancer; 2012 Jun; 22(5):812-8. PubMed ID: 22569105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage I endometrial adenocarcinoma: treatment results in 835 patients.
    Lotocki RJ; Copeland LJ; DePetrillo AD; Muirhead W
    Am J Obstet Gynecol; 1983 May; 146(2):141-5. PubMed ID: 6846429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of endometrial cancer with suspected cervical involvement.
    Mannel RS; Berman ML; Walker JL; Manetta A; DiSaia PJ
    Obstet Gynecol; 1990 Jun; 75(6):1016-22. PubMed ID: 2342727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.